# ADARx Pharmaceuticals Inc. (ADRX)

Source: https://www.quantisnow.com/company/ADRX
Generated: 2026-11-13T21:45:23.239Z

- Ticker: ADRX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2026
- SEC CIK: 0001802369

## About

ADARx Pharmaceuticals, Inc. is a late-stage biotechnology company dedicated to transforming cutting-edge science into next-generation siRNA therapeutics. We have developed technology designed to control the expression of specific disease drivers with highly selective RNA targeted therapies with the goal of delivering life-changing treatments for patients with unmet medical needs. ADARx is focused on advancing and expanding a deep pipeline of highly potent, durable and selective RNA-targeted therapeutic candidates, developing product candidates for the treatment of complement-mediated, genetic, cardiovascular, thrombosis, central nervous system and metabolic (obesity) diseases. In addition to our wholly-owned programs, we have entered into a collaboration and license option agreement with AbbVie to develop small interfering RNA (siRNA) therapeutics across multiple disease areas, including neuroscience, immunology and oncology.

## Latest ADRX news and filings

- 2026-11-13 21:13 UTC [SEC Schedule 13G] [SEC Form SCHEDULE 13G filed by ADARx Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-adarx-pharmaceuticals-inc-6790672)
- 2026-11-12 21:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by ADARx Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-adarx-pharmaceuticals-inc-6788115)
- 2026-11-12 21:05 UTC [SEC Form 8-K] [ADARx Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/adarx-pharmaceuticals-inc-filed-sec-form-8-k-results-of-operations-6787812)
- 2026-11-12 21:05 UTC [Earnings] [ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates](https://www.quantisnow.com/insight/adarx-reports-third-quarter-2026-financial-results-and-provides-business-6787705)
- 2026-11-09 13:00 UTC [Conference Announcement] [ADARx Pharmaceuticals to Present at the UBS Global Biopharma Conference](https://www.quantisnow.com/insight/adarx-pharmaceuticals-to-present-at-the-ubs-global-biopharma-conference-6780371)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ADRX
- Earnings history: https://www.quantisnow.com/earnings/ADRX
- Dividend history: https://www.quantisnow.com/dividends/ADRX
- Insider transactions: https://www.quantisnow.com/insiders/ADRX
- Options chain: https://www.quantisnow.com/options/ADRX
- SEC 8-K filings only: https://www.quantisnow.com/company/ADRX/8-k
- RSS and alerts for ADRX: https://www.quantisnow.com/docs/rss-feeds.md